Anzeige
Mehr »
Login
Donnerstag, 28.03.2024 Börsentäglich über 12.000 News von 687 internationalen Medien
Spezial am Donnerstag: Rallye II. - Neuer Anstoß, News und was die Börsencommunity jetzt nicht verpassen will…
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
15 Leser
Artikel bewerten:
(0)

Atul Mathur Named Executive Vice President of DaVita Global Operations

DENVER, Sept. 21, 2015 /PRNewswire/ -- DaVita HealthCare Partners (NYSE: DVA), a leading global provider of kidney care services and the leading independent medical group in the U.S., today announced that it has named Atul Mathur as executive vice president of global operations. Mathur has served as president of the Asia Pacific region since joining the company in 2011.

"We are excited to have Atul widen his focus on laying a strong foundation for our expanding international operations," said Kent Thiry, chairman and CEO of DaVita HealthCare Partners. "We also see a significant opportunity to develop high-quality, high-service outpatient care networks in a growing number of geographies."

In his new role, Mathur will take on additional responsibility of leading global strategy as well as organizational and international business development.

"There is significant growth potential not only in kidney care, but also in outpatient services internationally," said Dennis Kogod, CEO of DaVita HealthCare Partners International. "Atul is uniquely positioned to expand our high-quality clinical services to meet the increasing need."

Mathur previously enjoyed a 20 year career with American Express where he was SVP ofInternational Strategy, Business Development & Partnerships based in London. He and his wife Suniti will continue to be based in Singapore.

"It is an honor to serve in this expanded role at an exciting time for our organization," said Mathur. "DaVita HealthCare Partners is bringing better quality of life to more patients, in more places and it is a privilege to be part of this journey."

Mathur will report to Kogod and continue to have operational responsibility for the Asia Pacific Region.

About DaVita HealthCare Partners
DaVita HealthCare Partners Inc., a Fortune 500® company, is the parent company of DaVita Kidney Care and HealthCare Partners. DaVita Kidney Care is a leading provider of kidney care in the United States, delivering dialysis services to patients with chronic kidney failure and end stage renal disease. As of June 30, 2015, DaVita Kidney Care operated or provided administrative services at 2,210 outpatient dialysis centers located in the United States serving approximately 176,000 patients. The company also operated 96 outpatient dialysis centers located in 10 countries outside the United States. HealthCare Partners manages and operates medical groups and affiliated physician networks in Arizona, California, Nevada, New Mexico, Florida and Colorado in its pursuit to deliver excellent-quality health care in a dignified and compassionate manner. As of June 30, 2015, HealthCare Partners provided integrated care management for approximately 826,000 patients. For more information, please visit DaVitaHealthCarePartners.com.

Contact Information

Media:

David Tauchen
+1 (303) 876-2802
David.Tauchen@DaVita.com

Logo - http://photos.prnewswire.com/prnh/20140318/DC85712LOGO

Großer Dividenden-Report 2024 von Dr. Dennis Riedl
Der kostenlose Dividenden-Report zeigt ganz genau, wo Sie in diesem Jahr zuschlagen können. Das sind die Favoriten von Börsenprofi Dr. Dennis Riedl
Jetzt hier klicken
© 2015 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.